4.7 Article

Diagnostic Yield of Colonoscopy in Patients With Symptoms Compatible With Rome IV Functional Bowel Disorders

Journal

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 20, Issue 2, Pages 334-+

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2020.08.062

Keywords

Colonoscopy; Functional Bowel Disorders; Rome Criteria; Microscopic Colitis; Inflammatory Bowel Disease; Colorectal Cancer

Funding

  1. Health Research Authority (IRAS project) [253210]

Ask authors/readers for more resources

There is limited data on the diagnostic yield of colonoscopy in patients with symptoms compatible with functional bowel disorders (FBDs). This study aimed to determine the diagnostic outcomes of colonoscopy in FBD patients using Rome IV criteria and categorizing them based on the presence or absence of alarm features. The presence of organic disease was found to be significantly higher in patients with diarrheal disorders compared to constipation disorders, mainly due to microscopic colitis. Colonoscopy had no diagnostic value in patients without alarm features.
BACKGROUND & AIMS: There is little data on the diagnostic yield of colonoscopy in patients with symptoms compatible with functional bowel disorders (FBDs). Previous studies have only focused on diagnostic outcomes of colonoscopy in those with suspected irritable bowel syndrome using historic Rome I-III criteria, whilst having partially assessed for alarm features and shown markedly conflicting results. There is also no colonoscopy outcome data for other FBDs, such as functional constipation or functional diarrhea. Using the contemporaneous Rome IV criteria we determined the diagnostic yield of colonoscopy in patients with symptoms compatible with a FBD, stratified diligently according to the presence or absence of alarm features. METHODS: Basic demographics, alarm features, and bowel symptoms using the Rome IV diagnostic questionnaire were collected prospectively from adults attending out-patient colonoscopy in 2019. Endoscopists were blinded to the questionnaire data. Organic disease was defined as the presence of inflammatory bowel disease, colorectal cancer, or microscopic colitis. RESULTS: 646 patients fulfilled symptom-based criteria for the following Rome IV FBDs: IBS (56%), functional diarrhea (27%) and functional constipation (17%). Almost all had alarm features (98%). The combined prevalence of organic disease was 12%, being lowest for functional constipation and IBS-constipation (similar to 6% each), followed by IBS-mixed (similar to 9%), and highest amongst functional diarrhea and IBS-diarrhea ( similar to 17% each); p = .005. The increased prevalence of organic disease in diarrheal versus constipation disorders was accounted for by microscopic colitis (5.7% vs. 0%, p < .001) but not inflammatory bowel disease (7.2% vs. 4.0%, p = .2) or colorectal cancer (4.2% vs. 2.3%, p = .2). However, 1-in-4 chronic diarrhea patients - conceivably at risk for microscopic colitis - did not have colonic biopsies taken. Finally, only 11 of 646 (2%) patients were without alarm features, in whom colonoscopy was normal. CONCLUSIONS: Most patients with symptoms of FBDs who are referred for colonoscopy have alarm features. The presence of organic disease is significantly higher in diarrheal versus constipation disorders, with microscopic colitis largely accounting for the difference whilst also being a missed diagnostic opportunity. In those patients without alarm features, the diagnostic yield of colonoscopy was nil.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease

Sophie Parker, Olafur Palsson, David S. Sanders, Magnus Simren, Ami D. Sperber, Hans Tornblom, Heidi Urwin, William Whitehead, Imran Aziz

Summary: Individuals with celiac disease can experience gastrointestinal symptoms despite adhering to a gluten-free diet. This study found that half of the individuals with celiac disease who adhered to a gluten-free diet had functional gastrointestinal disorders, which was twice the rate compared to a matched control group. Furthermore, these individuals were more likely to have anxiety, depression, somatization, and reduced quality of life. Addressing gut-brain interaction disorders may improve outcomes in this specific group of patients.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Evidence-Based and Emerging Diet Recommendations for Small Bowel Disorders

Anupam Rej, Michael D. E. Potter, Nicholas J. Talley, Ayesha Shah, Gerald Holtmann, David Surendran Sanders

Summary: Diet plays a crucial role in the manifestation and severity of gastrointestinal symptoms, and there are potential dietary interventions for small bowel disorders. A gluten-free diet is the cornerstone of treatment for nonceliac gluten/wheat sensitivity, while elimination and elemental diets show promise in managing eosinophilic gastroenteritis, and antimicrobials are currently the established management option for small intestinal bacterial overgrowth.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet

Anupam Rej, David S. Sanders, Christian C. Shaw, Rachel Buckle, Nick Trott, Anurag Agrawal, Imran Aziz

Summary: This randomized trial compared the efficacy of traditional dietary advice (TDA) with low FODMAP diet (LFD) and gluten-free diet (GFD) in patients with non-constipated irritable bowel syndrome (IBS). The results showed that while all three diets were effective, TDA was the most suitable for patients in terms of cost and convenience.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Letter Gastroenterology & Hepatology

Reply

Anupam Rej, David S. Sanders, Imran Aziz

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Letter Gastroenterology & Hepatology

Further research needed to determine first-line therapy for IBS in primary care

Anupam Rej, David S. Sanders, Imran Aziz

Article Nutrition & Dietetics

Non-Responsive and Refractory Coeliac Disease: Experience from the NHS England National Centre

Hugo A. Penny, Anupam Rej, Elisabeth M. R. Baggus, Sarah. H. Coleman, Rosalie Ward, Graeme Wild, Gerd Bouma, Nick Trott, John A. Snowden, Josh Wright, Simon S. Cross, Marios Hadjivassiliou, David S. Sanders

Summary: This study characterized the causes of non-responsive coeliac disease (NRCD) and provided contemporary mortality data in refractory coeliac disease (RCD). The study also found a high frequency of positive urine gluten immunogenic peptides (GIPs) in patients with RCD1, suggesting common gluten exposure in this group.

NUTRIENTS (2022)

Review Medicine, General & Internal

Diet and irritable bowel syndrome: an update from a UK consensus meeting

A. Rej, A. Avery, I Aziz, C. J. Black, R. K. Bowyer, R. L. Buckle, L. Seamark, C. C. Shaw, J. Thompson, N. Trott, M. Williams, D. S. Sanders

Summary: There is a renewed interest in using dietary therapies to manage irritable bowel syndrome (IBS), with traditional dietary advice (TDA), gluten-free diet (GFD) and low FODMAP diet (LFD) being the main focus. Evidence shows that TDA is effective based on case control studies and clinical experience, while randomized controlled trials (RCT) have proven the benefits of soluble fiber in IBS. Short-term studies show the efficacy of GFD, but long-term outcomes are lacking. LFD has good evidence for short-term and long-term benefits. There is currently no evidence to suggest one diet is superior to another, but TDA is more acceptable to patients. Dietitians should assess dietary triggers and tailor interventions according to patient choice. Alternative approaches like group clinics and online webinars can improve accessibility for patients. Further research is needed to compare dietary therapies with other management strategies for IBS.

BMC MEDICINE (2022)

Article Gastroenterology & Hepatology

What are the clinical consequences of 'potential' coeliac disease?

Millie Newton, Emily A. Greenaway, William J. Holland, Suneil A. Raju, Anupam Rej, David S. Sanders

Summary: This study compared the clinical presentation of potential coeliac disease (PCD) with coeliac disease (CD). The findings showed that PCD patients had fewer extraintestinal manifestations and less haematinic deficiencies compared to CD patients. It was also observed that a gluten-free diet improved symptoms in PCD patients.

DIGESTIVE AND LIVER DISEASE (2023)

Article Gastroenterology & Hepatology

Diagnostic yield of upper gastrointestinal endoscopy in patients attending a UK centre with symptoms compatible with Rome IV functional dyspepsia

Hannah Lorraine-Francis, Ellen Newberry, Imran Aziz

Summary: Approximately 1 in 10 upper gastrointestinal endoscopies are performed in patients with symptoms compatible with FD and no alarm features, but these endoscopies do not provide any diagnostic yield. It is recommended to diagnose FD in these patients without the need for endoscopy.

FRONTLINE GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study

Hussain Jaafari, Lesley A. Houghton, Robert M. West, Anurag Agrawal, Imran Aziz, Christopher J. Black, Maura Corsetti, Farag Shuweihdi, Maria Eugenicos, Peter A. Paine, Alexander C. Ford, Peter J. Whorwell, Shrikant I. Bangdiwala, Olafur S. Palsson, Ami D. Sperber, Dipesh H. Vasant

Summary: This study compared the prevalence of disorders of gut brain interaction (DGBI) in the UK with other countries and found that the proportion of DGBI participants was lower in the UK. The prevalence of 14 out of 22 Rome IV DGBI was similar between the UK and other countries, while some specific DGBI were more prevalent in the UK. Differences in opioid prescribing, cultural, dietary, and lifestyle factors may contribute to variations in the prevalence of DGBI between the UK and other countries.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Nutrition & Dietetics

Does a Gluten-Free Diet Improve Quality of Life and Sleep in Patients with Non-Coeliac Gluten/Wheat Sensitivity?

Connor Cotton, Suneil A. Raju, Hamza Ahmed, Grace Webster, Rachel Hallam, Iain Croall, Sarah Coleman, Nick Trott, Anupam Rej, Mohamed G. Shiha, Imran Aziz, David S. Sanders

Summary: This study compared adherence to a gluten-free diet (GFD) in patients with coeliac disease (CD) and non-coeliac gluten/wheat sensitivity (NCGWS), and assessed its impact on quality of life and sleep. Results showed that patients with NCGWS had poorer adherence to GFD compared to CD, and this poorer adherence was associated with worse quality of life and sleep performance.

NUTRIENTS (2023)

No Data Available